One-Year Safety Analysis of the COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133+ Bone Marrow Stem Cells to Placebo in Patients after Acute Myocardial Infarction and Left Ventricular Dysfunction
Figure 2
Left ventricular ejection fraction improvement assessed by echocardiography for each randomized patient at baseline before treatment (), 4 months () and 12 months of followup (). Cardiac function was significantly improved at 4 and 12 months (). LVEF indicates left ventricular ejection fraction.
